0
0
10/12/23 at 3:54pm
Organization
Managedhealthcareexecutive.com
34 words
0
Comments
The findings reported in JAMA Cardiology suggest that Entresto is more cost effective in patients with heart failure with lower ejection fractions.
You are the first to view
https://www.managedhealthcareexecutive.com/view/analyzing-the-cost-effectiveness-of-entresto-in-heart-failure
Create an account
or login to join the discussion